AGR2 has been shown to participate in various cancer signalling pathways including Hippo, EGFR, EsR, cyclin D1, Src, c-Myc, survivin, aryl hydrocarbon receptor (AhR) and transforming growth factor-beta (TGF-β) [41]. The gene discussed is AGR2; the disease is cancer.